Arkolith/Insider Trading/QTTB/Form 4

Violette Shelia M.

Chief Scientific OfficerQ32 Bio Inc. (QTTB) · full profile →Form 4 · filed Oct 16, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2024Option exercise(M)6K$7.29$44K24K
Oct 11, 2024Option exercise(M)5K$3.12$14K18K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 15, 2024Option exercise(M)6K—$033K
Oct 11, 2024Option exercise(M)4K—$00
Oct 11, 2024Option exercise(M)213—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-115146) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML